Literature DB >> 17510404

Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells.

Masahiko Itoh1, Celeste M Nelson, Connie A Myers, Mina J Bissell.   

Abstract

Maintenance of apico-basal polarity in normal breast epithelial acini requires a balance between cell proliferation, cell death, and proper cell-cell and cell-extracellular matrix signaling. Aberrations in any of these processes can disrupt tissue architecture and initiate tumor formation. Here, we show that the small GTPase Rap1 is a crucial element in organizing acinar structure and inducing lumen formation. Rap1 activity in malignant HMT-3522 T4-2 cells is appreciably higher than in S1 cells, their nonmalignant counterparts. Expression of dominant-negative Rap1 resulted in phenotypic reversion of T4-2 cells, led to the formation of acinar structures with correct polarity, and dramatically reduced tumor incidence despite the persistence of genomic abnormalities and baseline growth. The resulting acini contained prominent central lumina not observed when other reverting agents were used. Conversely, expression of dominant-active Rap1 in T4-2 cells inhibited phenotypic reversion and led to increased invasiveness and tumorigenicity. Thus, Rap1 acts as a central regulator of breast architecture, with normal levels of activation instructing polarity during acinar morphogenesis, and increased activation inducing tumor formation and progression to malignancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510404      PMCID: PMC2841018          DOI: 10.1158/0008-5472.CAN-06-4246

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Rap1 GTPase regulation of adherens junction positioning and cell adhesion.

Authors:  Andrea L Knox; Nicholas H Brown
Journal:  Science       Date:  2002-02-15       Impact factor: 47.728

Review 2.  Rap1 signalling: adhering to new models.

Authors:  J L Bos; J de Rooij; K A Reedquist
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

3.  Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia.

Authors:  A J Dupuy; K Morgan; F C von Lintig; H Shen; H Acar; D E Hasz; N A Jenkins; N G Copeland; G R Boss; D A Largaespada
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

4.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.

Authors:  R D York; H Yao; T Dillon; C L Ellig; S P Eckert; E W McCleskey; P J Stork
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

5.  Alterations in the rap1 signaling pathway are common in human gliomas.

Authors:  D H Gutmann; S Saporito-Irwin; J E DeClue; R Wienecke; A Guha
Journal:  Oncogene       Date:  1997-09-25       Impact factor: 9.867

6.  ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini.

Authors:  S K Muthuswamy; D Li; S Lelievre; M J Bissell; J S Brugge
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

7.  Rapid Ca2+-mediated activation of Rap1 in human platelets.

Authors:  B Franke; J W Akkerman; J L Bos
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

8.  Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells.

Authors:  Q Gao; L Singh; A Kumar; S Srinivasan; D E Wazer; V Band
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.

Authors:  V M Weaver; O W Petersen; F Wang; C A Larabell; P Briand; C Damsky; M J Bissell
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

10.  The small GTPase, Rap1, mediates CD31-induced integrin adhesion.

Authors:  K A Reedquist; E Ross; E A Koop; R M Wolthuis; F J Zwartkruis; Y van Kooyk; M Salmon; C D Buckley; J L Bos
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  51 in total

Review 1.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

Review 2.  Ras and Rap1: A tale of two GTPases.

Authors:  Seema Shah; Ethan J Brock; Kyungmin Ji; Raymond R Mattingly
Journal:  Semin Cancer Biol       Date:  2018-04-03       Impact factor: 15.707

3.  Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.

Authors:  Xiaoyun Dong; Christopher Korch; Judy L Meinkoth
Journal:  Endocr Relat Cancer       Date:  2011-04-02       Impact factor: 5.678

4.  β-Arrestin 1-dependent regulation of Rap2 is required for fMLP-stimulated chemotaxis in neutrophil-like HL-60 cells.

Authors:  Nidhi Gera; Kenneth D Swanson; Tian Jin
Journal:  J Leukoc Biol       Date:  2016-08-04       Impact factor: 4.962

Review 5.  Integrins and epithelial cell polarity.

Authors:  Jessica L Lee; Charles H Streuli
Journal:  J Cell Sci       Date:  2014-07-02       Impact factor: 5.285

6.  Ras-related protein Rap2c promotes the migration and invasion of human osteosarcoma cells.

Authors:  Jinxia Wu; Wenqi Du; Xiucun Wang; Lulu Wei; Yaojie Pan; Xiaojin Wu; Jinling Zhang; Dongsheng Pei
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

Review 7.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02

Review 8.  Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.

Authors:  Britta Weigelt; Mina J Bissell
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 9.  EPAC proteins transduce diverse cellular actions of cAMP.

Authors:  Gillian Borland; Brian O Smith; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

10.  FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice.

Authors:  Sun-Young Lee; Roland Meier; Saori Furuta; Marc E Lenburg; Paraic A Kenny; Ren Xu; Mina J Bissell
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.